MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 558.00
-10.50 (-1.85%)
Sep 4, 2026, 5:30 PM CET
MedCap AB Market Cap
MedCap AB has a market cap or net worth of 8.36 billion as of September 4, 2026. Its market cap has decreased by -8.49% in one year.
Market Cap
8.36B
Enterprise Value
8.53B
Revenue
2.26B
Ranking
n/a
PE Ratio
34.73
Stock Price
558.00
ChartMarket Cap Chart
Since July 4, 2006, MedCap AB's market cap has increased from 37.25M to 8.36B, an increase of 22,334.66%. That is a compound annual growth rate of 30.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 8.36B | 0.95% |
| Dec 30, 2025 | 8.28B | -6.99% |
| Dec 30, 2024 | 8.90B | 78.07% |
| Dec 29, 2023 | 5.00B | 55.89% |
| Dec 30, 2022 | 3.21B | 21.63% |
| Dec 30, 2021 | 2.64B | -22.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 66.51B |
| Sectra AB | 56.03B |
| Elekta AB | 21.04B |
| Nolato AB | 14.30B |
| Vitrolife AB | 13.06B |
| Xvivo Perfusion AB | 8.32B |
| CellaVision AB | 3.88B |
| BICO Group AB | 1.57B |